What are the Future Directions in HSCT for Neonatal Disorders?
Research and innovation continue to improve the outcomes of HSCT. Future directions include:
Enhancing graft engineering techniques to reduce the risk of GVHD. Developing targeted therapies to minimize the toxicity of conditioning regimens. Exploring gene therapy as an alternative or adjunct to HSCT.
These advancements hold promise for safer and more effective treatments for neonates with life-threatening disorders.
